Skip to main content
. 2021 Jul 24;50(6):2105–2115. doi: 10.1093/ageing/afab146

Table 2 .

Primary and secondary outcomes in the CCB study

Intervention n = 153 (%) Control n = 153 (%) Risk difference (%) (95% CI) Risk ratio (95% CI) P-value risk ratio
Composite outcome
 3 months 63 (41.2) 59 (38.6) 2.6 (−8.4–13.6) 1.07 (0.81–1.41) 0.641
 6 months 83 (54.2) 73 (47.7) 6.5 (−4.7–18.0) 1.14 (0.91–1.42) 0.253
 12 months 101 (66.0) 88 (57.5) 8.5 (−2.4–19.3) 1.15 (0.96–1.37) 0.126
Unplanned readmission a
 3 months 45 (29.4) 48 (31.4) −1.9 (−12.2–8.3) 0.94 (0.67–1.32) 0.709
 6 months 60 (39.2) 59 (38.6) 0.7 (−10.3–11.6) 1.02 (0.77–1.35) 0.907
 12 months 73 (47.7) 70 (45.8) 1.9 (−0.2–13.1) 1.04 (0.82–1.32) 0.731
Mortality
 3 months 26 (17.0) 20 (13.1) 3.9 (−4.1–12.0) 1.30 (0.76–2.23) 0.337
 6 months 36 (23.5) 28 (18.3) 5.2 (−3.9–14.3) 1.29 (0.83–2.00) 0.261
 12 months 59 (38.6) 41 (26.8) 11.8 (1.3–22.2) 1.44 (1.04–2.00) 0.028

aResults are not corrected for (semi-)competing risk. Appendix 8 of supplementary data presents the for (semi-)competing risk corrected outcomes in a multi-state (illness-death) model.